Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (91-100 of 635) with videos related to

Pageof 64
Sort By:
European Heart Journal|January 13, 2006
Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarctionWei-Ching Chang, Padma Kaul, Yuling Fu, et al.
American Heart Journal|March 5, 2013
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionCynthia M Westerhout, Karen S Pieper, Stefan K James, et al.
American Heart Journal|April 30, 2013
Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approachesSumeet Subherwal, E Magnus Ohman, Kenneth W Mahaffey, et al.
Journal of the American College of Cardiology|October 30, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk ReductionJames L Januzzi, Jialin Xu, JingWei Li, et al.
American Heart Journal|March 30, 2006
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarctionPaul W Armstrong, Kenneth W Mahaffey, Wei-Ching Chang, et al.
Clinical Cardiology|August 12, 2018
Association of Healthcare Plan with atrial fibrillation prescription patternsAndrew Young Chang, Mariam Askari, Jun Fan, et al.
Coronary Artery Disease|January 6, 2012
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarctionJames S Mills, Kenneth W Mahaffey, Yuliya Lokhnygina, et al.
American Journal of Nephrology|January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS TrialDavid Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
Journal of the American College of Cardiology|April 28, 2022
Impact of Polyvascular Disease and Diabetes on Limb and Cardiovascular Risk in Peripheral Artery DiseaseSean A Behan, Hillary Mulder, Frank W Rockhold, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 26, 2009
Influence of body mass index on the efficacy of revascularization in patients with coronary artery diseaseAslan T Turer, Kenneth W Mahaffey, Emily Honeycutt, et al.
Pageof 64

Showing results (91-100 of 635) with videos related to

Sort By:
Pageof 64
European Heart Journal|January 13, 2006
Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarctionWei-Ching Chang, Padma Kaul, Yuling Fu, et al.
American Heart Journal|March 5, 2013
Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary interventionCynthia M Westerhout, Karen S Pieper, Stefan K James, et al.
American Heart Journal|April 30, 2013
Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approachesSumeet Subherwal, E Magnus Ohman, Kenneth W Mahaffey, et al.
Journal of the American College of Cardiology|October 30, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk ReductionJames L Januzzi, Jialin Xu, JingWei Li, et al.
American Heart Journal|March 30, 2006
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarctionPaul W Armstrong, Kenneth W Mahaffey, Wei-Ching Chang, et al.
Clinical Cardiology|August 12, 2018
Association of Healthcare Plan with atrial fibrillation prescription patternsAndrew Young Chang, Mariam Askari, Jun Fan, et al.
Coronary Artery Disease|January 6, 2012
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarctionJames S Mills, Kenneth W Mahaffey, Yuliya Lokhnygina, et al.
American Journal of Nephrology|January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS TrialDavid Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
Journal of the American College of Cardiology|April 28, 2022
Impact of Polyvascular Disease and Diabetes on Limb and Cardiovascular Risk in Peripheral Artery DiseaseSean A Behan, Hillary Mulder, Frank W Rockhold, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 26, 2009
Influence of body mass index on the efficacy of revascularization in patients with coronary artery diseaseAslan T Turer, Kenneth W Mahaffey, Emily Honeycutt, et al.
Pageof 64